ASGE Interventional IBD: Management of Complications (On-Demand)| March 2022-DEBATE: Dye-spray Chromoendoscopy is Better for Surveillance of Colitis-associate Neoplasia in all IBD Patients

DEBATE: Dye-spray Chromoendoscopy is Better for Surveillance of Colitis-associate Neoplasia in all IBD Patients

Video Transcription

Video Summary

In this video, Dr. Tanya Kotenberg, a professor of medicine at UC San Francisco, discusses the use of chromoendoscopy for surveillance of colitis-associated neoplasia in patients with inflammatory bowel disease (IBD). She emphasizes the importance of optimizing colorectal cancer surveillance in this high-risk group and reviews the indications for dysplasia in IBD. Dr. Kotenberg explains the various methods for dysplasia detection, including random biopsies, targeted biopsies, and chromoendoscopy. She advocates for the use of chromoendoscopy, which involves spraying a dye called indigo carmine to help visualize subtle lesions in the colon. The CYNIC trial found that chromoendoscopy was superior to other modalities for dysplasia detection. Dr. Kotenberg describes the technique of chromoendoscopy, highlights its limitations in cases of severe disease activity or strictures, and discusses the potential use of artificial intelligence in aiding dysplasia detection in the future. She also explains the nomenclature for describing dysplastic lesions seen through chromoendoscopy and emphasizes the importance of complete resection to prevent colon cancer. Dr. Kotenberg concludes by mentioning the recommendations for management of dysplastic lesions and the use of chromoendoscopy dye in guiding the resection process.

Asset Subtitle

Tonya R. Kaltenbach, MD, MS, FASGE

Meta Tag

Audience Generalist

Disease Inflammatory Bowel Disease

Keywords

chromoendoscopy

surveillance

colitis-associated neoplasia

inflammatory bowel disease

dysplasia detection